154.16 USD
+4.52 (+3.02%)
At close: Feb 6, 2026
154.16 USD
0 (0%)
After Hours: 2/6/2026, 8:00:01 PM
ICUI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. ICUI has an average financial health and profitability rating. ICUI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year ICUI was profitable.
- In the past year ICUI had a positive cash flow from operations.
- In multiple years ICUI reported negative net income over the last 5 years.
- ICUI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -0.18%, ICUI is in the better half of the industry, outperforming 73.12% of the companies in the same industry.
- With a decent Return On Equity value of -0.35%, ICUI is doing good in the industry, outperforming 73.66% of the companies in the same industry.
- ICUI has a Return On Invested Capital of 2.86%. This is in the better half of the industry: ICUI outperforms 70.43% of its industry peers.
- ICUI had an Average Return On Invested Capital over the past 3 years of 1.36%. This is significantly below the industry average of 8.80%.
- The 3 year average ROIC (1.36%) for ICUI is below the current ROIC(2.86%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROIC | 2.86% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
- ICUI has a better Operating Margin (5.63%) than 70.43% of its industry peers.
- In the last couple of years the Operating Margin of ICUI has declined.
- ICUI's Gross Margin of 36.47% is on the low side compared to the rest of the industry. ICUI is outperformed by 71.51% of its industry peers.
- In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
- The number of shares outstanding for ICUI has been increased compared to 1 year ago.
- The number of shares outstanding for ICUI has been increased compared to 5 years ago.
- Compared to 1 year ago, ICUI has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.28 indicates that ICUI is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.28, ICUI is doing good in the industry, outperforming 65.59% of the companies in the same industry.
- ICUI has a debt to FCF ratio of 21.21. This is a negative value and a sign of low solvency as ICUI would need 21.21 years to pay back of all of its debts.
- With a decent Debt to FCF ratio value of 21.21, ICUI is doing good in the industry, outperforming 69.35% of the companies in the same industry.
- ICUI has a Debt/Equity ratio of 0.62. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.62, ICUI is doing worse than 62.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Altman-Z | 2.28 |
ROIC/WACC0.29
WACC9.91%
2.3 Liquidity
- A Current Ratio of 2.45 indicates that ICUI has no problem at all paying its short term obligations.
- ICUI's Current ratio of 2.45 is in line compared to the rest of the industry. ICUI outperforms 51.08% of its industry peers.
- ICUI has a Quick Ratio of 1.19. This is a normal value and indicates that ICUI is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of ICUI (1.19) is worse than 67.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
- ICUI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.14%, which is quite impressive.
- ICUI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.28% yearly.
- Looking at the last year, ICUI shows a decrease in Revenue. The Revenue has decreased by -0.84% in the last year.
- ICUI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.47% yearly.
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-9.48%
3.2 Future
- Based on estimates for the next years, ICUI will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.56% on average per year.
- Based on estimates for the next years, ICUI will show a small growth in Revenue. The Revenue will grow by 2.95% on average per year.
EPS Next Y23.37%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue Next Year-4.9%
Revenue Next 2Y-3.64%
Revenue Next 3Y-1.17%
Revenue Next 5Y2.95%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 19.37, which indicates a rather expensive current valuation of ICUI.
- 83.33% of the companies in the same industry are more expensive than ICUI, based on the Price/Earnings ratio.
- ICUI is valuated rather cheaply when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 18.79, the valuation of ICUI can be described as rather expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ICUI indicates a rather cheap valuation: ICUI is cheaper than 83.33% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 27.77. ICUI is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.37 | ||
| Fwd PE | 18.79 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ICUI is valued cheaply inside the industry as 83.87% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICUI indicates a somewhat cheap valuation: ICUI is cheaper than 71.51% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 61.16 | ||
| EV/EBITDA | 14.47 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- ICUI's earnings are expected to grow with 14.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y14.84%
EPS Next 3Y14.98%
5. Dividend
5.1 Amount
- No dividends for ICUI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
154.16
+4.52 (+3.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-19 2026-02-19/amc
Inst Owners118.03%
Inst Owner Change-1.15%
Ins Owners0.96%
Ins Owner Change-1.94%
Market Cap3.81B
Revenue(TTM)2.32B
Net Income(TTM)-7.36M
Analysts83.33
Price Target185.03 (20.02%)
Short Float %4.79%
Short Ratio4.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.05%
Min EPS beat(2)37.25%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)36.86%
Min EPS beat(4)31.74%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)33.65%
EPS beat(12)12
Avg EPS beat(12)26.3%
EPS beat(16)15
Avg EPS beat(16)20.15%
Revenue beat(2)1
Avg Revenue beat(2)0.33%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)2.43%
Revenue beat(4)3
Avg Revenue beat(4)1.47%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)6
Avg Revenue beat(8)0.95%
Revenue beat(12)6
Avg Revenue beat(12)-0.92%
Revenue beat(16)8
Avg Revenue beat(16)-0.53%
PT rev (1m)0%
PT rev (3m)4.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.69%
EPS NY rev (1m)-0.44%
EPS NY rev (3m)7.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)0.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.37 | ||
| Fwd PE | 18.79 | ||
| P/S | 1.64 | ||
| P/FCF | 61.16 | ||
| P/OCF | 23.87 | ||
| P/B | 1.79 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.47 |
EPS(TTM)7.96
EY5.16%
EPS(NY)8.2
Fwd EY5.32%
FCF(TTM)2.52
FCFY1.64%
OCF(TTM)6.46
OCFY4.19%
SpS93.98
BVpS86.16
TBVpS-1.47
PEG (NY)0.83
PEG (5Y)N/A
Graham Number124.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROCE | 3.62% | ||
| ROIC | 2.86% | ||
| ROICexc | 3.12% | ||
| ROICexgc | 9.01% | ||
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% | ||
| FCFM | 2.68% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Debt/EBITDA | 3.95 | ||
| Cap/Depr | 47.91% | ||
| Cap/Sales | 4.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 47.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.28 |
F-Score7
WACC9.91%
ROIC/WACC0.29
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
EPS Next Y23.37%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-9.48%
Revenue Next Year-4.9%
Revenue Next 2Y-3.64%
Revenue Next 3Y-1.17%
Revenue Next 5Y2.95%
EBIT growth 1Y142.55%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year43.36%
EBIT Next 3Y18.75%
EBIT Next 5Y17.88%
FCF growth 1Y597.89%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y117.81%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%
ICU MEDICAL INC / ICUI FAQ
What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ICUI.
Can you provide the valuation status for ICU MEDICAL INC?
ChartMill assigns a valuation rating of 6 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.
What is the profitability of ICUI stock?
ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.
Can you provide the financial health for ICUI stock?
The financial health rating of ICU MEDICAL INC (ICUI) is 4 / 10.
What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?
The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 23.37% in the next year.